Position in OGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$10,118,367
-$39,226,762 QoQ
Shares Held
1,689,210
-75.5% QoQ
Ownership
0.643%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 93%
Shared 5%
None 2%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $6,486,971,678 across 12 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,539,098 | $2,676,614,716 | |
| 2 | PFE |
Pfizer Inc
|
56,551,011 | $1,361,748,341 | |
| 3 | ABBV |
AbbVie Inc.
|
4,388,338 | $1,104,281,370 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
6,651,833 | $840,392,576 | |
| 5 | LLY |
ELI LILLY & Co
|
145,790 | $174,864,912 | |
| 6 | BIIB |
Biogen Inc.
|
744,892 | $160,941,363 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
948,427 | $54,648,359 | |
| 8 | NVS |
Novartis AG
|
293,443 | $45,988,386 |
All Filings in OGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,118,367 | 1,689,210 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $49,345,129 | 6,882,166 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $101,482,447 | 9,502,102 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $99,096,121 | 10,237,203 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $159,552,973 | 10,715,445 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $147,634,397 | 9,895,067 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $186,676,409 | 9,758,307 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $208,882,062 | 10,090,921 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $190,873,520 | 10,152,847 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $147,242,732 | 10,211,008 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $161,106,005 | 9,280,300 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $184,049,173 | 8,844,266 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $196,680,494 | 8,362,266 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $210,533,655 | 7,537,904 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $177,261,011 | 7,575,257 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $254,146,611 | 7,530,270 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $226,361,593 | 6,480,435 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $175,703,136 | 5,770,218 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $160,520,951 | 4,895,424 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $174,957,326 | 5,781,802 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||